
2026 Symposium for Metabolic Health
A dedicated series of talks will explore the underlying metabolic drivers of obesity and type 2 diabetes, including insulin resistance, hormonal regulation, inflammation, and energy balance. Some sessions will also examine the role of GLP-1 based therapies, how they work, why some individuals experience limited or short-term results, and how these medications can be integrated into a comprehensive metabolic health approach.
Save 20% with code “HOPE”













